GSK unveils positive new data comparing Incruse Ellipta to tiotropium and glycopyrronium in COPD patients
Results from the randomised, blinded study 201316 showed that umeclidinium 62.5mcg once daily achieved a statistically significant improvement in lung function measured by trough forced expiratory volume in